Company Search:
Advanced Search
Sponsored Links
Circassia Pharmaceuticals PLC Company Snapshot
Circassia Pharmaceuticals PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Circassia Pharmaceuticals PLC with three other companies in this sector in the United Kingdom: GW Pharmaceuticals PLC (2018 sales of £20.00 million [US$26.39 million] of which 100% was Novel Therapeutics), Ergomed PLC (£54.11 million [US$71.39 million] of which 51% was Drug Safety and medical information serv), and Oxford BioMedica plc (£66.78 million [US$88.10 million] of which 82% was Platform).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Circassia Pharmaceuticals PLC
  Stock Performance Chart for Circassia Pharmaceuticals PLC
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 19.50p
(Figures in Pounds Sterling)
1 Week -16.7%   13 Weeks 15.4%  
4 Weeks 8.3%   52 Weeks -66.5%  
Circassia Pharmaceuticals PLC Key Data:
  Ticker: CIR Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 48,300,000
(Year Ending Jan 2019).
Employees: 367
  Currency: Pounds Sterling Market Cap: 73,144,500
  Fiscal Yr Ends: December Shares Outstanding: 375,100,000
  Share Type: Ordinary Closely Held Shares: 91,800,146
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.